Published in Lab Business Week, June 11th, 2006
Allergan also announced that its board of directors has declared a first quarter dividend of $0.10 per share, payable on June 13, 2006 to stockholders of record on May 19, 2006.
For the quarter ended March 31, 2006 Allergan's net sales were $615.2 million, excluding sales of products acquired in the Inamed acquisition, which was completed on March 23, 2006. Pharmaceutical sales increased 22.0%, or 23.0% at constant currency, compared to pharmaceutical sales in the first quarter of 2005.
Allergan reported $3.29 diluted loss per share...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.